Cognitive-behavioral therapy for obsessive-compulsive disorder as a comorbidity with schizophrenia or schizoaffective disorder

Psychotherapy and Psychosomatics

Volumn 81, Issue 1, 2011, Pages 58-60

  Tundo, Antonio ^a   Salvati, Loretta ^a   Di Spigno, Daniela ^a   Cieri, Luca ^a   Parena, Anita ^a   Necci, Roberta ^a   Sciortino, Stefania ^b  

^a Istituto di Psicopatologia   (Italy)

^b Centro Diurno 'Stella Polare' ASL RME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUVOXAMINE; NEUROLEPTIC AGENT;

ADULT; BEHAVIOR THERAPY; CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; LETTER; MALE; OBSESSIVE COMPULSIVE DISORDER; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; COGNITIVE THERAPY; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 82055200548     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000329455     Document Type: Letter

References (42)

1. Kruger S, Brauning P, Hoffler J, Shugar G, Borner I, Langkrar J: Prevalence of obsessive-compulsive disorder in schizophrenia and significance of motor symptoms. J Neuropsychiatry Clin Neurosci 2000; 12: 16-24. (Pubitemid 30093684)
2. Tibbo P, Kroetsch M, Chue P, Warneke L: Obsessive-compulsive disorder in schizophrenia. J Psychiatr Res 2000; 34: 139-146. (Pubitemid 30176122)
3. Nechmad A, Ratzoni G, Poyurovsky M, Meged S, Avidan G, Fuchs C, Bloch Y, Weizman R: Obsessive compulsive disorder in adolescent schizophrenia patients. Am J Psychiatry 2003; 160: 1002-1004. (Pubitemid 41079590)
4. Ohta M, Kokai M, Morita Y: Features of obsessive compulsive disorder in patients primarily diagnosed with schizophrenia. Psychiatry Clin Neurosci 2003; 57: 67-74. (Pubitemid 36227551)
5. Poyurovsky M, Bergman J, Weizman R: Obsessive-compulsive disorder in elderly schizophrenia patients. J Psychiatr Res 2006; 40: 189-191. (Pubitemid 43214624)
6. Achim AM, Maziade M, Raymond E, Olivier D, Mérette C, Roy MA: How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull 2011; 37: 811-821.
7. Fenton WS, McGlashgan TH: The prognostic significance of obsessivecompulsive symptoms in schizophrenia. Am J Psychiatry 1986; 143: 437-441. (Pubitemid 16119747)
8. Berman I, Kalinowski A, Berman SM, Lengua J, Green Al: Obsessivecompulsive symptoms in chronic schizophrenia. Compr Psychiatry 1995; 36: 6-10.
9. Poyurovsky M, Hromnikov S, Isakov V, Rauchverger B, Modai L, Schnedman M, Fuchs C, Weizman A: Obsessive-compulsive disorder in chronic institutionalized schizophrenic patients. Psychiatry Res 2001; 102: 49-57. (Pubitemid 32463924)
10. Craic T, Hwang MY, Bromet EJ: Obsessive-compulsive and panic symptoms in patients with first-admission psychosis. Am J Psychiatry 2002; 159: 592-598. (Pubitemid 34274941)
11. Cunill R, Castells X, Simeon D: Relationships between obsessivecompulsive symptomatology and severity of psychosis in schizophrenia: a systematic review and meta-analysis. J Clin Psychiatry 2009; 70: 70-82.
12. Tiryaki A, Ozkorumak E: Do the obsessive-compulsive symptoms have an effect in schizophrenia? Compr Psychiatry 2010; 51: 357-362.
13. American Psychiatric Association: Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry 2007; 164(suppl):1-56.
14. Poyurovsky M, Weizman A, Weizman R: Obsessive-compulsive disorder in schizophrenia. CNS Drugs 2004; 18: 989-1010.
15. Yaryuro-Tobias JA, Neziroglu F: The action of clomipramine in obsessive compulsive neurosis: a pilot study. Curr Ther Res Clin Exp 1975; 17: 111-116.
16. Zohar J, Kaplan Z, Benjamin J: Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients. J Clin Psychiatry 1993; 54: 385-388. (Pubitemid 23358260)
17. Kurokawa K, Tanino R: Effectiveness of clorimipramine for obsessive compulsive symptoms and chronic pain in two patients with schizophrenia. J Clin Psychopharmacol 1997; 17: 329-330. (Pubitemid 27312440)
18. Hwang MY, Martin AM, Lindenmayer JP, Stein D, Hollander E: Treatment of schizophrenia with obsessive compulsive features with serotonin reuptake inhibitors (letter). Am J Psychiatry 1993; 150: 1127. (Pubitemid 23198641)
19. Sewell DD, Lopez WM, Paulsen J, Gilbert P: Treatment of obsessive compulsive symptoms in schizophrenia with a neuroleptic-selective serotonin reuptake inhibitor combination: two case reports. J Nerv Ment Dis 1994; 182: 725-727.
20. Tejera CA, Mayerhoff DJ, Safferman AZ, Ramos-Lorenzi JR: Fluoxetine for obsessional symptoms in schizophrenia. Am J Psychiatry 1994; 151: 149-150.
21. Scholl HP, Kasper S, Danos P, Hoflich G, Moller HJ: Selective serotonin reuptake inhibitors in the treatment of compulsive symptoms within the scope of schizophrenia (in German). Nervenarzt 1994; 65: 478-481. (Pubitemid 24234799)
22. Poyurovsky M, Kurs R, Weizman A: Olanzapine-sertraline combination in schizophrenia with obsessive compulsive disorder (letter). J Clin Psychiatry 2003; 64: 611. (Pubitemid 36618295)
23. Reznik I, Sirota P: Obsessive and compulsive symptoms in schizophrenia: a randomized controlled trial with fluvoxamine and neuroleptics. J Clin Psychopharmacol 2000; 20: 410-416. (Pubitemid 30463756)
24. Bark N, Lindenmayer JP: Ineffectiveness of clomipramine for obsessive compulsive symptoms in a patient with schizophrenia. Am J Psychiatry 1992; 149: 136-137.
25. Lindenmayer JP, Vakharia M, Kanofsky D: Fluoxetine in chronic schizophrenia (letter). J Clin Psychopharmacol 1990; 10: 76.
26. Baker RW: Fluoxetine and schizophrenia in a patient with obsessional thinking. J Neuropsychiatry Clin Neurosci 1992; 4: 232-233.
27. Poyurovsky M, Isakov V, Hromnikov S, Modai L, Rauchberger B, Schneidman M, Weizman A: Fluvoxamine treatment of obsessivecompulsive symptoms in schizophrenic patients: an add-on open study. Int Clin Psychopharmacol 1999; 14: 95-100. (Pubitemid 29149868)
28. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, DSM IV, ed 4. Washington, American Psychiatric Association, 1994.
29. First MB, Spitzer RL, Gibbon M, Janet BW: Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Clinical Version. Washington, American Psychiatric Press, 1996.
30. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS: The Yale-Brown Obsessive-Compulsive Scale. I. Development, use and reliability. Arch Gen Psychiatry 1989; 46: 1006-1011. (Pubitemid 19278229)
31. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS: The Yale-Brown Obsessive-Compulsive Scale. II. Validity. Arch Gen Psychiatry 1989; 46: 1012-1016.
32. Kay SR, Fiszbein A, Oplert LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261-276. (Pubitemid 18039085)
33. Kozak MJ, Foa EB: Mastery of Obsessive-Compulsive Disorder: A Cognitive-Behavioral Approach. San Antonio, The Psychological Corporation, 1997.
34. Guy W: ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, National Institute of Mental Health, 1976, pp 218-222.
35. Jones SH, Thornicroft G, Coffey M, Dunn G: A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF). Br J Psychiatry 1995; 166: 654-659.
36. Abramowitz JS: Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review. J Consult Clin Psychol 1997; 65: 44-52. (Pubitemid 27086134)
37. Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ, Henk HJ: Behavioral versus pharmacological treatments of obsessive-compulsive disorder: a meta-analysis. Psychopharmacology 1998; 136: 205-216. (Pubitemid 28143169)
38. Lucey JV, Butcher G, Clare AW, Dinan TG: The clinical characteristics of patients with obsessive-compulsive disorders: a descriptive study of an Irish sample. Int J Psychol Med 1994; 11: 11-14. (Pubitemid 24120993)
39. Tundo A, Salvati L, Busto G, Di SPigno D, Falcini R: Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study. J Clin Psychiatry 2007; 68: 1552-1556. (Pubitemid 350073404)
40. Kampman M, Keijsers GPG, Hoogduin CAL, Verbraak MJPM: Addition of cognitive-behaviour therapy for obsessive-compulsive disorder patients non-responding to fluoxetine. Acta Psychiatr Scand 2002; 106: 314-319.
41. Tolin DF, Maltby N, Diefenbach GJ, Hannan SE, Worhunsky P: Cognitive-behavioral therapy for medication nonresponders with obsessivecompulsive disorder: a wait-list-controlled open trial. J Clin Psychiatry 2004; 65: 922-931.
42. Simpson HB, Gorfinkle KS, Liebowitz MR: Cognitive-behavioral therapy as adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial. J Clin Psychiatry 1999; 60: 584-590. (Pubitemid 29451554)